Benjamin Ungar
Benjamin Ungar
1
Present address:
Department of Dermatology and Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
New York
1,1,#,
Susan Hartzell
Susan Hartzell
2
Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
1
Present address:
Department of Dermatology and Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
New York
2,1,#,
Daniel Lozano‐Ojalvo
Daniel Lozano‐Ojalvo
2
Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
1
Present address:
Department of Dermatology and Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
New York
2,1,#,
Sabrina Ghalili
Sabrina Ghalili
1
Present address:
Department of Dermatology and Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
New York
1,
Swaroop Bose
Swaroop Bose
1
Present address:
Department of Dermatology and Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
New York
1,
Alexandra K Golant
Alexandra K Golant
1
Present address:
Department of Dermatology and Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
New York
1,
Kathryn Tan
Kathryn Tan
1
Present address:
Department of Dermatology and Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
New York
1,
Yeriel D Estrada
Yeriel D Estrada
1
Present address:
Department of Dermatology and Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
New York
1,
Giselle K Singer
Giselle K Singer
1
Present address:
Department of Dermatology and Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
New York
1,
Ana B Pavel
Ana B Pavel
1
Present address:
Department of Dermatology and Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
New York
3
Department of Biomedical Engineering, the University of Mississippi, University
1,3,
Paolo Cravedi
Paolo Cravedi
2
Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
2,a,✉,
Emma Guttman‐Yassky
Emma Guttman‐Yassky
1
Present address:
Department of Dermatology and Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
New York
1,a,✉
1
Present address:
Department of Dermatology and Laboratory of Inflammatory Skin Diseases
Icahn School of Medicine at Mount Sinai
New York
2
Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
3
Department of Biomedical Engineering, the University of Mississippi, University
*
Correspondence
,
Emma Guttman‐Yassky, Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, 5 E. 98 Street, New York, New York 10029,
Email: emma.guttman@mssm.edu
,
Paolo Cravedi, MD, PhD, Department of Medicine and Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, 1 Gustave Levy Place, New York, New York 10029,
Email: paolo.cravedi@mssm.edu
#Contributed equally to this work
aContributed equally to this work
Revised 2022 Sep 19; Received 2022 May 4; Accepted 2022 Sep 25.
Keywords: COVID‐19, SARS‐CoV‐2, dupilumab, T cell, atopic dermatitis, Th1, Th2
This article is protected by copyright. All rights reserved.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.
